Clinical trials: real world data plays early role in efforts to increase diversity

RAPS

5 September 2022 - The use of real world data to help design clinical trials is nothing new but increasingly it is being used early in the process to boost trial diversity and inclusion.

In April 2022, the FDA issued draft guidance on developing formal diversity plans to improve enrolment of participants from underrepresented racial and ethnic populations in clinical trials.

Read Regulatory Affairs Professional Society article

Michael Wonder

Posted by:

Michael Wonder